Early PSA decrease is an independent predictive factor of clinical failure and specific survival in patients with localized prostate cancer treated by radiotherapy with or without androgen deprivation therapy-Reference-Cited by-同舟云学术

Early PSA decrease is an independent predictive factor of clinical failure and specific survival in patients with localized prostate cancer treated by radiotherapy with or without androgen deprivation therapy

Published:2010-04 Issue:4 Volume:21 Page:808-814
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

de Crevoisier R.,Slimane K.,Messai T.,Wibault P.,Eschwege F.,Bossi A.,Koscielny S.,Bridier A.,Massard C.,Fizazi K.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/21/4/808/364403/mdp365.pdf

Reference30 articles.

1. Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial;Bolla;Lancet,2002

2. 6-month androgen suppression plus radiation therapy vs radiation therapy alone for patients with clinically localized prostate cancer: a randomized controlled trial;D’Amico;JAMA,2004

3. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer;D’Amico;JAMA,1998

4. Radiation therapy for clinically localized prostate cancer: a multi-institutional pooled analysis;Shipley;JAMA,1999

5. Pretreatment prostate-specific antigen doubling times: clinical utility of this predictor of prostate cancer behavior;Hanks;Int J Radiat Oncol Biol Phys,1996

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multitask Learning of Longitudinal Circulating Biomarkers and Clinical Outcomes: Identification of Optimal Machine-Learning and Deep-Learning Models;2023-08-21

2. Early PSA density kinetics predicts biochemical and local failure following extreme hypofractionated radiotherapy in intermediate-risk prostate cancer;Radiotherapy and Oncology;2022-04

3. Comparison of Joint and Landmark Modeling for Predicting Cancer Progression in Men With Castration-Resistant Prostate Cancer;JAMA Network Open;2021-06-15

4. Interim Prostate-Specific Antigen: Predicting for Biochemical Failure During Salvage Radiation Therapy After Prostatectomy;Advances in Radiation Oncology;2021-03

5. Stereotactic body radiotherapy with periprostatic hydrogel spacer for localized prostate cancer: toxicity profile and early oncologic outcomes;Radiation Oncology;2019-08-02